Biologic response modifiers presently approved in the USA for use in various rheumatic inflammatory diseases include three TNF inhibitors (etanercept, infliximab and adalimumab), a B-cell-directed ...

The potential of biologic agents to influence malignant processes has revolutionized cancer therapy. The biologic therapy causes modulation of immune responses ...

Please provide your email address to receive an email when new articles are posted on . Men, along with clinicians with more than 4 years’ experience, were more likely than women and less experienced ...

Biological therapy (sometimes called immunotherapy, biotherapy, or biological response modifier therapy) is a relatively new addition to the family of cancer treatments that also includes surgery, ...

: Starting a biologic response modifier was associated with a reduction in physician visits and use of expensive procedures for patients with RA within 2 to 3 years of initiation. Use of ...